News
Public · Published
Sasken Selected to Support Strategic Connectivity Platform Programme with Leading European Automotive Software Company
Sasken Technologies announced a multi-year engineering engagement with the software company of a leading European automotive group. It will provide software development, systems integration, hardware engineering and validation services for next-generation telematics control units used in global vehicle platforms.
Published:
Updated:
What happened
Sasken Technologies announced a multi-year engineering engagement with the software company of a leading European automotive group. It will provide software development, systems integration, hardware engineering and validation services for next-generation telematics control units used in global vehicle platforms.
Confirmed
Global impact / market context
The work gives Sasken a role in developing vehicle connectivity systems that support services such as diagnostics and over-the-air updates. If the programme progresses into commercial deployment, it could generate engineering revenue over several years and deepen Sasken’s automotive customer relationships.
Analyst inference
The article describes growing use of software-defined vehicles, where software supports more vehicle functions, and identifies telematics control units as a foundation for connected services. It does not disclose the engagement’s value, expected revenue, delivery timetable, or financial contribution.
Confirmed
What to watch
- Watch for details on the programme’s timetable and commercial deployment, since these would indicate when engineering work could translate into revenue for Sasken. Analyst inference
- Watch for any disclosed contract value or revenue contribution; the announcement gives no financial terms, so the engagement’s potential scale remains unclear. Analyst inference
- Watch for updates on Sasken’s engineering work across software, hardware and validation, and whether the programme extends to multiple international vehicle markets as stated. Confirmed
Evidence
- Original source link unavailable